TVTX
Travere Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$65.28
−1.89%0
Insider buys (3m)
8
Insider sells (3m)
-$1.4M
Net value (3m)
+43.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 3, 2026 | Cline Christopher R. · officer: CHIEF FINANCIAL OFFICER | Sale | 642 | $66 |
| Aug 19, 2026 | LYONS GARY A · director | Sale | 500 | $64 |
| Aug 19, 2026 | LYONS GARY A · director | Sale | 4,100 | $63 |
| Aug 19, 2026 | LYONS GARY A · director | M-Exempt | 5,000 | $17 |
| Aug 19, 2026 | LYONS GARY A · director | Sale | 1,900 | $63 |
| Aug 19, 2026 | LYONS GARY A · director | Sale | 900 | $64 |
| Aug 19, 2026 | LYONS GARY A · director | Sale | 2,600 | $63 |
| Jun 16, 2026 | Coughlin Timothy · director | Sale | 10,000 | $50 |
| Jun 16, 2026 | Coughlin Timothy · director | M-Exempt | 10,000 | $27 |
| Jun 16, 2026 | Baynes Roy D. · director | M-Exempt | 4,500 | $21 |
| Jun 16, 2026 | Baynes Roy D. · director | Sale | 4,500 | $50 |
| May 21, 2026 | Squarer Ron · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Coughlin Timothy · director | A-Award | 12,000 | $42 |
| May 21, 2026 | Williams Brinkley Ruth · director | A-Award | 12,000 | $42 |
| May 21, 2026 | Coughlin Timothy · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Orwin John A · director | A-Award | 12,000 | $42 |
| May 21, 2026 | Baynes Roy D. · director | A-Award | 12,000 | $42 |
| May 21, 2026 | Orwin John A · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Bruhn Suzanne Louise · director | A-Award | 12,000 | $42 |
| May 21, 2026 | Poole Sandra · director | A-Award | 12,000 | $42 |
| May 21, 2026 | LYONS GARY A · director | A-Award | 12,000 | $42 |
| May 21, 2026 | Squarer Ron · director | A-Award | 12,000 | $42 |
| May 21, 2026 | Williams Brinkley Ruth · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Bruhn Suzanne Louise · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Poole Sandra · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Meckler Jeffrey A · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Meckler Jeffrey A · director | A-Award | 12,000 | $42 |
| May 21, 2026 | LYONS GARY A · director | A-Award | 4,000 | $0.00 |
| May 21, 2026 | Baynes Roy D. · director | A-Award | 4,000 | $0.00 |
| May 19, 2026 | Coughlin Timothy · director | Sale | 3,250 | $43 |
Institutional positioning
13F filings over the trailing two quarters
New 137Increased 215Reduced 183Sold out 29
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | Increased | 11,419,586 | May 18, 2026 |
| Jupiter Topco LLC | New Position | 11,324,191 | Aug 14, 2026 |
| FMR LLC | Increased | 10,967,967 | May 15, 2026 |
| BlackRock, Inc. | Increased | 8,020,663 | Aug 7, 2026 |
| BLACKROCK, INC. | Reduced | 7,792,033 | May 13, 2026 |
| FMR LLC | Reduced | 7,096,614 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 4,959,988 | May 15, 2026 |
| ARMISTICE CAPITAL, LLC | Increased | 4,897,417 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 4,568,341 | Aug 14, 2026 |
| STATE STREET CORP | Reduced | 4,256,224 | Aug 7, 2026 |
| PERCEPTIVE ADVISORS LLC | Reduced | 4,142,551 | May 29, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 4,108,694 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 4,045,812 | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Reduced | 3,752,574 | Aug 14, 2026 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | Reduced | 3,270,513 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 3, 2026